Ottolina Jessica, Villanacci Roberta, D'Alessandro Sara, He Xuemin, Grisafi Giorgia, Ferrari Stefano Maria, Candiani Massimo
IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy.
Obstetrics and Gynecology Unit, Department of Biomedical Sciences and Human Oncology, University of "Aldo Moro", 70124 Bari, Italy.
J Clin Med. 2024 Jul 9;13(14):3996. doi: 10.3390/jcm13143996.
Endometriosis and adenomyosis are complex gynecological conditions characterized by diverse clinical presentations, including superficial peritoneal endometriosis (SPE), ovarian endometrioma (OMA), and deep infiltrating endometriosis (DIE). The hallmark features of these pathologies involve the manifestation of pain symptoms and infertility, and approximately 30% of patients are asymptomatic. Despite ongoing research, definitive treatments for these conditions remain elusive, and clinical management primarily revolves around medical or surgical interventions. Recent advancements in our understanding of the efficacy of various treatment modalities, including medical therapy and surgical interventions, have provided clinicians with valuable insights into pain relief and fertility preservation. This review aims to provide an updated overview of the latest literature on clinical outcomes, treatment options, and management strategies for different types of endometriosis. By synthesizing the newest available data, this review seeks to inform clinicians and guide decision making based on factors such as patients' symptom severity, childbearing desire, and overall health.
子宫内膜异位症和子宫腺肌病是复杂的妇科疾病,其临床表现多样,包括浅表性腹膜子宫内膜异位症(SPE)、卵巢子宫内膜异位囊肿(OMA)和深部浸润性子宫内膜异位症(DIE)。这些病症的标志性特征包括疼痛症状和不孕的表现,约30%的患者无症状。尽管研究不断,但这些病症的明确治疗方法仍然难以捉摸,临床管理主要围绕药物或手术干预。我们对包括药物治疗和手术干预在内的各种治疗方式疗效的最新认识进展,为临床医生提供了有关缓解疼痛和保留生育能力的宝贵见解。本综述旨在提供有关不同类型子宫内膜异位症临床结局、治疗选择和管理策略的最新文献的最新概述。通过综合最新可得数据,本综述旨在为临床医生提供信息,并根据患者症状严重程度、生育愿望和整体健康等因素指导决策。